nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—Melatonin—CYP1B1—ovarian cancer	0.0153	0.597	CrCbGaD
Midodrine—Melatonin—ESR1—ovarian cancer	0.0103	0.403	CrCbGaD
Midodrine—Confusional state—Chlorambucil—ovarian cancer	0.00542	0.00556	CcSEcCtD
Midodrine—Scotoma—Doxorubicin—ovarian cancer	0.00537	0.00552	CcSEcCtD
Midodrine—Flushing—Vinorelbine—ovarian cancer	0.00535	0.00549	CcSEcCtD
Midodrine—Cardiac disorder—Vinorelbine—ovarian cancer	0.00535	0.00549	CcSEcCtD
Midodrine—Angiopathy—Vinorelbine—ovarian cancer	0.00523	0.00536	CcSEcCtD
Midodrine—Hyperaesthesia—Doxorubicin—ovarian cancer	0.0052	0.00534	CcSEcCtD
Midodrine—Dry skin—Paclitaxel—ovarian cancer	0.00513	0.00527	CcSEcCtD
Midodrine—Vasodilation procedure—Epirubicin—ovarian cancer	0.00502	0.00515	CcSEcCtD
Midodrine—Vasodilation—Epirubicin—ovarian cancer	0.00502	0.00515	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00496	0.00509	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00485	0.00498	CcSEcCtD
Midodrine—Back pain—Vinorelbine—ovarian cancer	0.00485	0.00498	CcSEcCtD
Midodrine—Dyspepsia—Chlorambucil—ovarian cancer	0.00473	0.00485	CcSEcCtD
Midodrine—Nervous system disorder—Topotecan—ovarian cancer	0.00469	0.00481	CcSEcCtD
Midodrine—Skin disorder—Topotecan—ovarian cancer	0.00465	0.00477	CcSEcCtD
Midodrine—Vasodilation procedure—Doxorubicin—ovarian cancer	0.00464	0.00477	CcSEcCtD
Midodrine—Vasodilation—Doxorubicin—ovarian cancer	0.00464	0.00477	CcSEcCtD
Midodrine—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00464	0.00476	CcSEcCtD
Midodrine—Pain—Chlorambucil—ovarian cancer	0.0046	0.00472	CcSEcCtD
Midodrine—Tachycardia—Melphalan—ovarian cancer	0.00457	0.00469	CcSEcCtD
Midodrine—Skin disorder—Melphalan—ovarian cancer	0.00455	0.00467	CcSEcCtD
Midodrine—Dysuria—Paclitaxel—ovarian cancer	0.00453	0.00465	CcSEcCtD
Midodrine—Pollakiuria—Paclitaxel—ovarian cancer	0.00447	0.00459	CcSEcCtD
Midodrine—Feeling abnormal—Chlorambucil—ovarian cancer	0.00443	0.00454	CcSEcCtD
Midodrine—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00439	0.00451	CcSEcCtD
Midodrine—Dry skin—Docetaxel—ovarian cancer	0.00435	0.00447	CcSEcCtD
Midodrine—Hypertension—Vinorelbine—ovarian cancer	0.00433	0.00444	CcSEcCtD
Midodrine—Paraesthesia—Topotecan—ovarian cancer	0.0043	0.00441	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00428	0.00439	CcSEcCtD
Midodrine—Dyspnoea—Topotecan—ovarian cancer	0.00426	0.00438	CcSEcCtD
Midodrine—Abdominal pain—Chlorambucil—ovarian cancer	0.00425	0.00436	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00424	0.00435	CcSEcCtD
Midodrine—Dyspepsia—Topotecan—ovarian cancer	0.00421	0.00432	CcSEcCtD
Midodrine—Stomatitis—Paclitaxel—ovarian cancer	0.00421	0.00432	CcSEcCtD
Midodrine—Paraesthesia—Melphalan—ovarian cancer	0.00421	0.00432	CcSEcCtD
Midodrine—Dyspnoea—Melphalan—ovarian cancer	0.00418	0.00429	CcSEcCtD
Midodrine—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00413	0.00424	CcSEcCtD
Midodrine—Dyspepsia—Melphalan—ovarian cancer	0.00412	0.00423	CcSEcCtD
Midodrine—Pain—Topotecan—ovarian cancer	0.00409	0.0042	CcSEcCtD
Midodrine—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.00408	0.00419	CcSEcCtD
Midodrine—Cramps of lower extremities—Epirubicin—ovarian cancer	0.00405	0.00416	CcSEcCtD
Midodrine—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00404	0.00415	CcSEcCtD
Midodrine—Nervous system disorder—Vinorelbine—ovarian cancer	0.00401	0.00412	CcSEcCtD
Midodrine—Pain—Melphalan—ovarian cancer	0.00401	0.00411	CcSEcCtD
Midodrine—Tachycardia—Vinorelbine—ovarian cancer	0.00399	0.0041	CcSEcCtD
Midodrine—Skin disorder—Vinorelbine—ovarian cancer	0.00397	0.00408	CcSEcCtD
Midodrine—Bradycardia—Paclitaxel—ovarian cancer	0.00394	0.00405	CcSEcCtD
Midodrine—Feeling abnormal—Topotecan—ovarian cancer	0.00394	0.00405	CcSEcCtD
Midodrine—Gastrointestinal pain—Topotecan—ovarian cancer	0.00391	0.00401	CcSEcCtD
Midodrine—Asthenia—Chlorambucil—ovarian cancer	0.00386	0.00396	CcSEcCtD
Midodrine—Urinary tract disorder—Paclitaxel—ovarian cancer	0.00383	0.00393	CcSEcCtD
Midodrine—Pruritus—Chlorambucil—ovarian cancer	0.0038	0.0039	CcSEcCtD
Midodrine—Urethral disorder—Paclitaxel—ovarian cancer	0.0038	0.0039	CcSEcCtD
Midodrine—Abdominal pain—Topotecan—ovarian cancer	0.00378	0.00388	CcSEcCtD
Midodrine—Cramps of lower extremities—Doxorubicin—ovarian cancer	0.00375	0.00385	CcSEcCtD
Midodrine—Paraesthesia—Vinorelbine—ovarian cancer	0.00367	0.00377	CcSEcCtD
Midodrine—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00366	0.00376	CcSEcCtD
Midodrine—Erythema multiforme—Paclitaxel—ovarian cancer	0.00366	0.00376	CcSEcCtD
Midodrine—Dyspnoea—Vinorelbine—ovarian cancer	0.00365	0.00374	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00363	0.00372	CcSEcCtD
Midodrine—Flushing—Paclitaxel—ovarian cancer	0.0036	0.00369	CcSEcCtD
Midodrine—Cardiac disorder—Paclitaxel—ovarian cancer	0.0036	0.00369	CcSEcCtD
Midodrine—Stomatitis—Docetaxel—ovarian cancer	0.00357	0.00366	CcSEcCtD
Midodrine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00353	0.00363	CcSEcCtD
Midodrine—Angiopathy—Paclitaxel—ovarian cancer	0.00352	0.00361	CcSEcCtD
Midodrine—Pain—Vinorelbine—ovarian cancer	0.0035	0.00359	CcSEcCtD
Midodrine—Chills—Paclitaxel—ovarian cancer	0.00348	0.00357	CcSEcCtD
Midodrine—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00346	0.00355	CcSEcCtD
Midodrine—Asthenia—Topotecan—ovarian cancer	0.00343	0.00352	CcSEcCtD
Midodrine—Mental disorder—Paclitaxel—ovarian cancer	0.00339	0.00348	CcSEcCtD
Midodrine—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00339	0.00348	CcSEcCtD
Midodrine—Pruritus—Topotecan—ovarian cancer	0.00338	0.00347	CcSEcCtD
Midodrine—Feeling abnormal—Vinorelbine—ovarian cancer	0.00337	0.00346	CcSEcCtD
Midodrine—Asthenia—Melphalan—ovarian cancer	0.00336	0.00345	CcSEcCtD
Midodrine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00335	0.00343	CcSEcCtD
Midodrine—Flatulence—Paclitaxel—ovarian cancer	0.00332	0.00341	CcSEcCtD
Midodrine—Pruritus—Melphalan—ovarian cancer	0.00331	0.0034	CcSEcCtD
Midodrine—Tension—Paclitaxel—ovarian cancer	0.00331	0.0034	CcSEcCtD
Midodrine—Nervousness—Paclitaxel—ovarian cancer	0.00328	0.00336	CcSEcCtD
Midodrine—Back pain—Paclitaxel—ovarian cancer	0.00326	0.00335	CcSEcCtD
Midodrine—Urinary tract disorder—Docetaxel—ovarian cancer	0.00324	0.00333	CcSEcCtD
Midodrine—Muscle spasms—Paclitaxel—ovarian cancer	0.00324	0.00333	CcSEcCtD
Midodrine—Abdominal pain—Vinorelbine—ovarian cancer	0.00324	0.00332	CcSEcCtD
Midodrine—Urethral disorder—Docetaxel—ovarian cancer	0.00322	0.0033	CcSEcCtD
Midodrine—Nausea—Chlorambucil—ovarian cancer	0.00319	0.00328	CcSEcCtD
Midodrine—Dizziness—Topotecan—ovarian cancer	0.00316	0.00325	CcSEcCtD
Midodrine—Erythema multiforme—Docetaxel—ovarian cancer	0.0031	0.00319	CcSEcCtD
Midodrine—Agitation—Paclitaxel—ovarian cancer	0.0031	0.00318	CcSEcCtD
Midodrine—Cardiac disorder—Docetaxel—ovarian cancer	0.00305	0.00313	CcSEcCtD
Midodrine—Flushing—Docetaxel—ovarian cancer	0.00305	0.00313	CcSEcCtD
Midodrine—Rash—Topotecan—ovarian cancer	0.00302	0.0031	CcSEcCtD
Midodrine—Dermatitis—Topotecan—ovarian cancer	0.00301	0.00309	CcSEcCtD
Midodrine—Headache—Topotecan—ovarian cancer	0.003	0.00308	CcSEcCtD
Midodrine—Angiopathy—Docetaxel—ovarian cancer	0.00298	0.00306	CcSEcCtD
Midodrine—Rash—Melphalan—ovarian cancer	0.00295	0.00303	CcSEcCtD
Midodrine—Dermatitis—Melphalan—ovarian cancer	0.00295	0.00303	CcSEcCtD
Midodrine—Chills—Docetaxel—ovarian cancer	0.00295	0.00302	CcSEcCtD
Midodrine—Asthenia—Vinorelbine—ovarian cancer	0.00294	0.00301	CcSEcCtD
Midodrine—Dry skin—Epirubicin—ovarian cancer	0.00293	0.00301	CcSEcCtD
Midodrine—Hypertension—Paclitaxel—ovarian cancer	0.00291	0.00299	CcSEcCtD
Midodrine—Pruritus—Vinorelbine—ovarian cancer	0.0029	0.00297	CcSEcCtD
Midodrine—Mental disorder—Docetaxel—ovarian cancer	0.00288	0.00295	CcSEcCtD
Midodrine—Anxiety—Paclitaxel—ovarian cancer	0.00286	0.00294	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00285	0.00293	CcSEcCtD
Midodrine—Nausea—Topotecan—ovarian cancer	0.00284	0.00292	CcSEcCtD
Midodrine—Dry mouth—Paclitaxel—ovarian cancer	0.00281	0.00288	CcSEcCtD
Midodrine—Nausea—Melphalan—ovarian cancer	0.00278	0.00286	CcSEcCtD
Midodrine—Confusional state—Paclitaxel—ovarian cancer	0.00278	0.00285	CcSEcCtD
Midodrine—Back pain—Docetaxel—ovarian cancer	0.00277	0.00284	CcSEcCtD
Midodrine—Muscle spasms—Docetaxel—ovarian cancer	0.00275	0.00282	CcSEcCtD
Midodrine—Dry skin—Doxorubicin—ovarian cancer	0.00272	0.00279	CcSEcCtD
Midodrine—Dizziness—Vinorelbine—ovarian cancer	0.00271	0.00278	CcSEcCtD
Midodrine—Nervous system disorder—Paclitaxel—ovarian cancer	0.0027	0.00277	CcSEcCtD
Midodrine—Tachycardia—Paclitaxel—ovarian cancer	0.00269	0.00276	CcSEcCtD
Midodrine—Skin disorder—Paclitaxel—ovarian cancer	0.00267	0.00274	CcSEcCtD
Midodrine—Dysuria—Epirubicin—ovarian cancer	0.00259	0.00266	CcSEcCtD
Midodrine—Rash—Vinorelbine—ovarian cancer	0.00258	0.00265	CcSEcCtD
Midodrine—Dermatitis—Vinorelbine—ovarian cancer	0.00258	0.00265	CcSEcCtD
Midodrine—Headache—Vinorelbine—ovarian cancer	0.00256	0.00263	CcSEcCtD
Midodrine—Pollakiuria—Epirubicin—ovarian cancer	0.00256	0.00262	CcSEcCtD
Midodrine—Insomnia—Paclitaxel—ovarian cancer	0.00249	0.00256	CcSEcCtD
Midodrine—Paraesthesia—Paclitaxel—ovarian cancer	0.00247	0.00254	CcSEcCtD
Midodrine—Hypertension—Docetaxel—ovarian cancer	0.00247	0.00253	CcSEcCtD
Midodrine—Dyspnoea—Paclitaxel—ovarian cancer	0.00245	0.00252	CcSEcCtD
Midodrine—Somnolence—Paclitaxel—ovarian cancer	0.00245	0.00251	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00245	0.00251	CcSEcCtD
Midodrine—Nausea—Vinorelbine—ovarian cancer	0.00243	0.00249	CcSEcCtD
Midodrine—Dyspepsia—Paclitaxel—ovarian cancer	0.00242	0.00249	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00242	0.00248	CcSEcCtD
Midodrine—Stomatitis—Epirubicin—ovarian cancer	0.00241	0.00247	CcSEcCtD
Midodrine—Dysuria—Doxorubicin—ovarian cancer	0.00239	0.00246	CcSEcCtD
Midodrine—Dry mouth—Docetaxel—ovarian cancer	0.00238	0.00244	CcSEcCtD
Midodrine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00238	0.00244	CcSEcCtD
Midodrine—Pollakiuria—Doxorubicin—ovarian cancer	0.00237	0.00243	CcSEcCtD
Midodrine—Pain—Paclitaxel—ovarian cancer	0.00235	0.00242	CcSEcCtD
Midodrine—Confusional state—Docetaxel—ovarian cancer	0.00235	0.00241	CcSEcCtD
Midodrine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00233	0.00239	CcSEcCtD
Midodrine—Nervous system disorder—Docetaxel—ovarian cancer	0.00229	0.00235	CcSEcCtD
Midodrine—Tachycardia—Docetaxel—ovarian cancer	0.00228	0.00234	CcSEcCtD
Midodrine—Feeling abnormal—Paclitaxel—ovarian cancer	0.00227	0.00233	CcSEcCtD
Midodrine—Skin disorder—Docetaxel—ovarian cancer	0.00227	0.00233	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00226	0.00232	CcSEcCtD
Midodrine—Bradycardia—Epirubicin—ovarian cancer	0.00225	0.00231	CcSEcCtD
Midodrine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00225	0.00231	CcSEcCtD
Midodrine—Stomatitis—Doxorubicin—ovarian cancer	0.00223	0.00228	CcSEcCtD
Midodrine—Urinary tract disorder—Epirubicin—ovarian cancer	0.00219	0.00224	CcSEcCtD
Midodrine—Abdominal pain—Paclitaxel—ovarian cancer	0.00218	0.00223	CcSEcCtD
Midodrine—Urethral disorder—Epirubicin—ovarian cancer	0.00217	0.00223	CcSEcCtD
Midodrine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00216	0.00222	CcSEcCtD
Midodrine—Insomnia—Docetaxel—ovarian cancer	0.00211	0.00217	CcSEcCtD
Midodrine—Paraesthesia—Docetaxel—ovarian cancer	0.00209	0.00215	CcSEcCtD
Midodrine—Erythema multiforme—Epirubicin—ovarian cancer	0.00209	0.00215	CcSEcCtD
Midodrine—Bradycardia—Doxorubicin—ovarian cancer	0.00209	0.00214	CcSEcCtD
Midodrine—Dyspnoea—Docetaxel—ovarian cancer	0.00208	0.00213	CcSEcCtD
Midodrine—Somnolence—Docetaxel—ovarian cancer	0.00207	0.00213	CcSEcCtD
Midodrine—Flushing—Epirubicin—ovarian cancer	0.00206	0.00211	CcSEcCtD
Midodrine—Cardiac disorder—Epirubicin—ovarian cancer	0.00206	0.00211	CcSEcCtD
Midodrine—Dyspepsia—Docetaxel—ovarian cancer	0.00205	0.00211	CcSEcCtD
Midodrine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00202	0.00208	CcSEcCtD
Midodrine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00201	0.00207	CcSEcCtD
Midodrine—Angiopathy—Epirubicin—ovarian cancer	0.00201	0.00206	CcSEcCtD
Midodrine—Urethral disorder—Doxorubicin—ovarian cancer	0.00201	0.00206	CcSEcCtD
Midodrine—Pain—Docetaxel—ovarian cancer	0.002	0.00205	CcSEcCtD
Midodrine—Chills—Epirubicin—ovarian cancer	0.00199	0.00204	CcSEcCtD
Midodrine—Asthenia—Paclitaxel—ovarian cancer	0.00197	0.00203	CcSEcCtD
Midodrine—Pruritus—Paclitaxel—ovarian cancer	0.00195	0.002	CcSEcCtD
Midodrine—Mental disorder—Epirubicin—ovarian cancer	0.00194	0.00199	CcSEcCtD
Midodrine—Erythema multiforme—Doxorubicin—ovarian cancer	0.00194	0.00199	CcSEcCtD
Midodrine—Feeling abnormal—Docetaxel—ovarian cancer	0.00192	0.00197	CcSEcCtD
Midodrine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00191	0.00196	CcSEcCtD
Midodrine—Flushing—Doxorubicin—ovarian cancer	0.0019	0.00195	CcSEcCtD
Midodrine—Cardiac disorder—Doxorubicin—ovarian cancer	0.0019	0.00195	CcSEcCtD
Midodrine—Flatulence—Epirubicin—ovarian cancer	0.0019	0.00195	CcSEcCtD
Midodrine—Tension—Epirubicin—ovarian cancer	0.00189	0.00194	CcSEcCtD
Midodrine—Nervousness—Epirubicin—ovarian cancer	0.00187	0.00192	CcSEcCtD
Midodrine—Back pain—Epirubicin—ovarian cancer	0.00187	0.00191	CcSEcCtD
Midodrine—Angiopathy—Doxorubicin—ovarian cancer	0.00186	0.00191	CcSEcCtD
Midodrine—Muscle spasms—Epirubicin—ovarian cancer	0.00185	0.0019	CcSEcCtD
Midodrine—Abdominal pain—Docetaxel—ovarian cancer	0.00184	0.00189	CcSEcCtD
Midodrine—Chills—Doxorubicin—ovarian cancer	0.00184	0.00189	CcSEcCtD
Midodrine—Dizziness—Paclitaxel—ovarian cancer	0.00182	0.00187	CcSEcCtD
Midodrine—Mental disorder—Doxorubicin—ovarian cancer	0.0018	0.00184	CcSEcCtD
Midodrine—Agitation—Epirubicin—ovarian cancer	0.00177	0.00182	CcSEcCtD
Midodrine—Flatulence—Doxorubicin—ovarian cancer	0.00176	0.0018	CcSEcCtD
Midodrine—Tension—Doxorubicin—ovarian cancer	0.00175	0.0018	CcSEcCtD
Midodrine—Rash—Paclitaxel—ovarian cancer	0.00174	0.00178	CcSEcCtD
Midodrine—Dermatitis—Paclitaxel—ovarian cancer	0.00173	0.00178	CcSEcCtD
Midodrine—Nervousness—Doxorubicin—ovarian cancer	0.00173	0.00178	CcSEcCtD
Midodrine—Back pain—Doxorubicin—ovarian cancer	0.00173	0.00177	CcSEcCtD
Midodrine—Headache—Paclitaxel—ovarian cancer	0.00172	0.00177	CcSEcCtD
Midodrine—Muscle spasms—Doxorubicin—ovarian cancer	0.00172	0.00176	CcSEcCtD
Midodrine—Asthenia—Docetaxel—ovarian cancer	0.00167	0.00172	CcSEcCtD
Midodrine—Hypertension—Epirubicin—ovarian cancer	0.00166	0.00171	CcSEcCtD
Midodrine—Pruritus—Docetaxel—ovarian cancer	0.00165	0.00169	CcSEcCtD
Midodrine—Agitation—Doxorubicin—ovarian cancer	0.00164	0.00168	CcSEcCtD
Midodrine—Anxiety—Epirubicin—ovarian cancer	0.00164	0.00168	CcSEcCtD
Midodrine—Nausea—Paclitaxel—ovarian cancer	0.00163	0.00168	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00163	0.00167	CcSEcCtD
Midodrine—Dry mouth—Epirubicin—ovarian cancer	0.00161	0.00165	CcSEcCtD
Midodrine—Confusional state—Epirubicin—ovarian cancer	0.00159	0.00163	CcSEcCtD
Midodrine—Nervous system disorder—Epirubicin—ovarian cancer	0.00154	0.00158	CcSEcCtD
Midodrine—Dizziness—Docetaxel—ovarian cancer	0.00154	0.00158	CcSEcCtD
Midodrine—Hypertension—Doxorubicin—ovarian cancer	0.00154	0.00158	CcSEcCtD
Midodrine—Tachycardia—Epirubicin—ovarian cancer	0.00154	0.00158	CcSEcCtD
Midodrine—Skin disorder—Epirubicin—ovarian cancer	0.00153	0.00157	CcSEcCtD
Midodrine—Anxiety—Doxorubicin—ovarian cancer	0.00151	0.00155	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00151	0.00155	CcSEcCtD
Midodrine—Dry mouth—Doxorubicin—ovarian cancer	0.00149	0.00152	CcSEcCtD
Midodrine—Rash—Docetaxel—ovarian cancer	0.00147	0.00151	CcSEcCtD
Midodrine—Dermatitis—Docetaxel—ovarian cancer	0.00147	0.00151	CcSEcCtD
Midodrine—Confusional state—Doxorubicin—ovarian cancer	0.00147	0.00151	CcSEcCtD
Midodrine—Headache—Docetaxel—ovarian cancer	0.00146	0.0015	CcSEcCtD
Midodrine—Nervous system disorder—Doxorubicin—ovarian cancer	0.00143	0.00147	CcSEcCtD
Midodrine—Insomnia—Epirubicin—ovarian cancer	0.00142	0.00146	CcSEcCtD
Midodrine—Tachycardia—Doxorubicin—ovarian cancer	0.00142	0.00146	CcSEcCtD
Midodrine—Skin disorder—Doxorubicin—ovarian cancer	0.00141	0.00145	CcSEcCtD
Midodrine—Paraesthesia—Epirubicin—ovarian cancer	0.00141	0.00145	CcSEcCtD
Midodrine—Dyspnoea—Epirubicin—ovarian cancer	0.0014	0.00144	CcSEcCtD
Midodrine—Somnolence—Epirubicin—ovarian cancer	0.0014	0.00144	CcSEcCtD
Midodrine—Nausea—Docetaxel—ovarian cancer	0.00139	0.00142	CcSEcCtD
Midodrine—Dyspepsia—Epirubicin—ovarian cancer	0.00139	0.00142	CcSEcCtD
Midodrine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00136	0.00139	CcSEcCtD
Midodrine—Pain—Epirubicin—ovarian cancer	0.00135	0.00138	CcSEcCtD
Midodrine—Insomnia—Doxorubicin—ovarian cancer	0.00132	0.00135	CcSEcCtD
Midodrine—Paraesthesia—Doxorubicin—ovarian cancer	0.00131	0.00134	CcSEcCtD
Midodrine—Dyspnoea—Doxorubicin—ovarian cancer	0.0013	0.00133	CcSEcCtD
Midodrine—Feeling abnormal—Epirubicin—ovarian cancer	0.0013	0.00133	CcSEcCtD
Midodrine—Somnolence—Doxorubicin—ovarian cancer	0.00129	0.00133	CcSEcCtD
Midodrine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00129	0.00132	CcSEcCtD
Midodrine—Dyspepsia—Doxorubicin—ovarian cancer	0.00128	0.00132	CcSEcCtD
Midodrine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00126	0.00129	CcSEcCtD
Midodrine—Pain—Doxorubicin—ovarian cancer	0.00125	0.00128	CcSEcCtD
Midodrine—Abdominal pain—Epirubicin—ovarian cancer	0.00124	0.00128	CcSEcCtD
Midodrine—Feeling abnormal—Doxorubicin—ovarian cancer	0.0012	0.00123	CcSEcCtD
Midodrine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00119	0.00122	CcSEcCtD
Midodrine—Abdominal pain—Doxorubicin—ovarian cancer	0.00115	0.00118	CcSEcCtD
Midodrine—Asthenia—Epirubicin—ovarian cancer	0.00113	0.00116	CcSEcCtD
Midodrine—Pruritus—Epirubicin—ovarian cancer	0.00111	0.00114	CcSEcCtD
Midodrine—Asthenia—Doxorubicin—ovarian cancer	0.00104	0.00107	CcSEcCtD
Midodrine—Dizziness—Epirubicin—ovarian cancer	0.00104	0.00107	CcSEcCtD
Midodrine—Pruritus—Doxorubicin—ovarian cancer	0.00103	0.00106	CcSEcCtD
Midodrine—Rash—Epirubicin—ovarian cancer	0.000992	0.00102	CcSEcCtD
Midodrine—Dermatitis—Epirubicin—ovarian cancer	0.000991	0.00102	CcSEcCtD
Midodrine—Headache—Epirubicin—ovarian cancer	0.000986	0.00101	CcSEcCtD
Midodrine—Dizziness—Doxorubicin—ovarian cancer	0.000963	0.000988	CcSEcCtD
Midodrine—Nausea—Epirubicin—ovarian cancer	0.000935	0.000959	CcSEcCtD
Midodrine—Rash—Doxorubicin—ovarian cancer	0.000918	0.000942	CcSEcCtD
Midodrine—Dermatitis—Doxorubicin—ovarian cancer	0.000917	0.000941	CcSEcCtD
Midodrine—Headache—Doxorubicin—ovarian cancer	0.000912	0.000936	CcSEcCtD
Midodrine—Nausea—Doxorubicin—ovarian cancer	0.000865	0.000888	CcSEcCtD
